Total renin after gonadotropin stimulation in polycystic ovarian disease.
OBJECTIVE
To examine the influence of polycystic ovarian disease (PCOD) on the levels of total renin in plasma and follicular fluid (FF) after stimulation with hMG.


METHODS
Comparative study of the plasma and FF concentrations of total renin in women with and without PCOD after stimulation with hMG.


METHODS
In vitro fertilization-embryo transfer program at the Department of Obstetrics and Gynecology, the University Central Hospital of Turku, Finland.


METHODS
Thirty-six women undergoing IVF-ET for infertility with (n = 10) or without (n = 26) ultrasonographically diagnosed PCOD. Of the latter group, 15 women had tubal infertility, and the rest suffered from an anovulatory infertility and reacted with PCO-like ovarian response to stimulation.


METHODS
The concentrations of total renin in plasma and FF, serum E2, and protein in FF.


RESULTS
The concentrations of plasma total renin after the gonadotropin stimulation were significantly higher in the PCOD and PCO-like groups when compared with the tubal group. The concentration of total renin in FF and the ratio of total renin per protein in FF were higher in the PCOD and PCO-like groups than in the tubal group, but the differences did not reach statistical significance. Positive correlations were found between the plasma total renin and serum E2 concentrations in the PCO-like and in the tubal group and between plasma total renin concentrations and the number of mature follicles in all groups. Follicular fluid total renin did not correlate with FF protein in any group. All findings were independent of the total hMG dosage used and the body mass index of the patients.


CONCLUSIONS
In the present study the concentrations of total renin in plasma were enhanced markedly after gonadotropin stimulation in women with PCOD compared with women having tubal infertility. The pattern of the hormonal secretions revealed a group of infertile patients reacting biochemically like women with PCOD.
University Central Hospital of Turku, Finland.
I
I
Matinlauri
L
L
Anttila
T A
TA
Jaatinen
P
P
Koskinen
M
M
Aalto
K
K
Irjala
V
V
Nikkanen
D000328:Adult; D004624:Embryo Transfer; D004958:Estradiol / Q000097:blood; D005184:Fallopian Tube Diseases / Q000097:blood / Q000150:complications; D005260:Female; D005307:Fertilization in Vitro; D015571:Follicular Fluid / Q000378:metabolism; D006801:Humans; D007247:Infertility, Female / Q000209:etiology / Q000628:therapy; D008596:Menotropins / Q000008:administration & dosage / Q000627:therapeutic use; D010062:Ovulation Induction; D011085:Polycystic Ovary Syndrome / Q000097:blood* / Q000150:complications / Q000000981:diagnostic imaging; D012083:Renin / Q000097:blood* / Q000378:metabolism; D014463:Ultrasonography
D004958:Estradiol; D008596:Menotropins; D012083:Renin